Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Angion Biomedica's Return On Capital Employed Overview

Benzinga Pro data, Angion Biomedica (NASDAQ:ANGN) reported Q1 sales of $1.65 million. Earnings fell to a loss of $14.24 million, resulting in a 195.63% decrease from last quarter.

INVO Bioscience's Return On Capital Employed Overview

INVO Bioscience's Return On Capital Employed Overview

INVO Bioscience (NASDAQ:INVO) brought in sales totaling $162.60 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2959.58%, resulting in a loss of $2.77 million.

Here's How Much $100 Invested In Nasdaq 10 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Nasdaq 10 Years Ago Would Be Worth Today

Nasdaq (NASDAQ:NDAQ) has outperformed the market over the past 10 years by 10.7% on an annualized basis producing an average annual return of 21.71%. Currently, Nasdaq has a market capitalization of $25.13 billion.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Neptune Wellness Solutions Shares Are Nosediving Today

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares are trading lower by 32.2% to $1.97 after the company announced a $5 million registered direct offering.

Why Exela Technologies Shares Are Popping Off Today

Exela Technologies Inc (NASDAQ: XELA) shares are trading higher by 27.4% to $0.17 after the company announced a new customer win of $136 million in total contract value.

Worksport Launches Storefronts On Amazon, eBay And Walmart Marketplace

Worksport Ltd (NASDAQ:WKSP) has launched its eCommerce storefronts on Amazon.com (NASDAQ:AMZN), eBay (NASDAQ:EBAY), and Walmart (NYSE:WMT) Marketplace. N.A. Williams Company will execute Worksport’s marketing campaigns on each platform with account executives and marketing managers. The move is expected to drive sales higher and is the result of the company’s restructuring plan. “Our teams and I are thrilled to provide our…

GBS: GBS' Prints Are All Over It

By John Vandermosten, CFA NASDAQ:GBS READ THE FULL GBS RESEARCH REPORT

inkl

Read news from The Economist, FT, and more,
with one subscription

10 Psychedelics CEOs To Pay Attention To In 2022

10 Psychedelics CEOs To Pay Attention To In 2022

By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public.

Expert Ratings for Blink Charging

Expert Ratings for Blink Charging

Blink Charging (NASDAQ:BLNK) has observed the following analyst ratings within the last quarter:

Expert Ratings for Pennant Gr

Expert Ratings for Pennant Gr

Within the last quarter, Pennant Gr (NASDAQ:PNTG) has observed the following analyst ratings:

Where Regency Centers Stands With Analysts

Where Regency Centers Stands With Analysts

Analysts have provided the following ratings for Regency Centers (NASDAQ:REG) within the last quarter:

Analyzing Nasdaq's Short Interest

Analyzing Nasdaq's Short Interest

Nasdaq's (NASDAQ:NDAQ) short percent of float has risen 5.19% since its last report. The company recently reported that it has 1.62 million shares sold short, which is 1.42% of all regular shares that are available for trading.

Expert Ratings for Sonder Holdings

Expert Ratings for Sonder Holdings

Sonder Holdings (NASDAQ:SOND) has observed the following analyst ratings within the last quarter:

What 9 Analyst Ratings Have To Say About Intuitive Surgical

What 9 Analyst Ratings Have To Say About Intuitive Surgical

Within the last quarter, Intuitive Surgical (NASDAQ:ISRG) has observed the following analyst ratings:

Get all your
news in one place.

100’s of premium titles.
One news app.

Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants

Moderna Inc (NASDAQ:MRNA) has released new clinical data on its bivalent (omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the omicron subvariants BA.4 and BA.5. The company is working on completing regulatory submissions…

Morgan Stanley Sees Further Share Gains For AMD - Read Why

Morgan Stanley analyst Joseph Moore reinstated Advanced Micro Devices, Inc (NASDAQ: AMD) wi

Why Mullen Automotive Shares Are Gaining Today

Mullen Automotive Inc (NASDAQ:MULN) has filed over 130 patents in 24 countries for Mullen FIVE EV Crossover program. The patent applications are related to the design and styling of the Mullen FIVE EV Crossover, covering its exterior and interior design. The patent applications include 19 U.S. design patent filings and 117 international design…

Uber, Lyft Drivers File Antitrust Case Against Ride Hailing Companies

A group of Uber Technologies, Inc (NYSE:UBER) and Lyft, Inc (NASDAQ:LYFT) drivers slapped an antitrust lawsuit on the companies for unfairly controlling passenger fares. The drivers claimed that lower consumer fares would provide them with "the most competitive compensation." The suit adds that companies hurt driver earnings by charging higher fares to the customers. The lawsuit…

Get all your
news in one place.

100’s of premium titles.
One news app.

Softbank Continues To Lose Key Official In Quick Succession

Softbank Group Corp (OTC:SFTBY) (OTC:SFTBF) SoftBank Group International named SBGI Managing Partner Alex Clavel as CEO, effective June 30. Clavel, a seven-year veteran in the company, succeeded Michel Combes, who departed to pursue new opportunities after five years in the company. Combes had assumed the CEO position five months back, succeeding former SoftBank…

Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy.

Read Why This Analyst Cut Bed Bath And Beyond's Price Target By 60%

Telsey Advisory Group analyst Cristina Fernández lowered the price target on Bed Bath & Beyond Inc (NASDAQ:BBBY) to $6 from $15, implying a 10.45% downside. The analyst maintained an Underperform rating on the shares. The analyst is taking a subdued view due to more negative commentary from mass retailers like Big Lots, Inc. (NYSE:BIG), Target Corp (NYSE:TGT), and Walmart Inc (NYSE:WMT)…

Options Traders Expect Tesla To Zoom Ahead

Shares of Tesla Inc (NASDAQ: TSLA) spiked on Tuesday after the company announced layoffs amid supply chain bottlenecks.

Is Facebook Losing Out To TikTok? Brazilian Investment Bank Liquidates 4-Year Long Position In Meta

Meta Platforms, Inc. (NASDAQ: META) stock is slowly losing its appeal among institutional investors amid its recent fundamental setbacks.

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

Here's a roundup of top developments in the biotech space over the last 24 hours:

Why Quotient Stock Is Soaring Today

Quotient Ltd (NASDAQ: QTNT) shares are trading higher Wednesday after the company issued guidance above analyst estimates. Quotient announced that it has rescheduled its financial results to June 24. The company provided a preview of its results in accordance with the rescheduling.

1 … 364 365 366 367

People

John Vandermosten

Cristina Fernández

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wikimedia Commons

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play